title: Alanine scanning mutants of the HIV gp41 loop.
abstract: Based on mutagenesis and structural studies of human immunodeficiency virus (HIV) envelope proteins, the loop region of gp41 is thought to directly interact with gp120. The importance of the HIV gp41 loop region to envelope function has been systematically examined by alanine scanning of all gp41 loop residues and the subsequent characterization of the mutagenic effects on viral entry, envelope expression, envelope processing, and gp120 association with gp41. With respect to the wild-type gp41, mutational effects on viral entry fall into four classes as follows: 1) little or no effect (G594A, S599A, G600A, K601A, N611A, S615A, N616A, and L619A); 2) significantly reduced entry (I595A, L602A, I603A, V608A, and K617A); 3) abolished entry (L593A, W596A, G597A, T606A, W610A, W614A, S618A, and I622A); and 4) enhanced entry (T605A, P609A, S613A, E620A, and Q621A). The reduced functionality of many mutants was apparently due to either disruption of envelope processing (L593A and T606A), viral incorporation of the envelope (W610A, W614A, and I662A), or increased dissociation of gp120 (W596A, G597A, and S618A). The extreme sensitivity of the gp120-gp41 interaction to alanine substitutions (e.g. the G597A and S618A mutants are relatively conservative substitutions) suggests that this association is an attractive and novel target for future drug discovery efforts.
authors.affiliation: Department of Biochemistry and Molecular Genetics, University of Illinois, Chicago, Illinois 60607, USA.
authors.forename: Amy
authors.initials: A
authors.lastname: Jacobs
authors.forename: Jayita
authors.initials: J
authors.lastname: Sen
authors.forename: Lijun
authors.initials: L
authors.lastname: Rong
authors.forename: Michael
authors.initials: M
authors.lastname: Caffrey
mesh_terms: D000409:Alanine / Q000235:genetics; D019943:Amino Acid Substitution; D001665:Binding Sites / Q000235:genetics; D015699:HIV Envelope Protein gp120 / Q000378:metabolism; D015700:HIV Envelope Protein gp41 / Q000235:genetics* / Q000378:metabolism / Q000502:physiology; D015497:HIV-1 / Q000235:genetics* / Q000472:pathogenicity / Q000502:physiology; D006801:Humans; D016297:Mutagenesis, Site-Directed
chemical_list: D015699:HIV Envelope Protein gp120; D015700:HIV Envelope Protein gp41; D000409:Alanine